{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:10:16Z","timestamp":1770833416477,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"DOI":"10.1093\/infdis\/jiab502","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T03:17:25Z","timestamp":1633058245000},"page":"926-927","source":"Crossref","is-referenced-by-count":2,"title":["Posttreatment Transaminase Elevations in Controlled Human Malaria Infection and Naturally Acquired Malaria"],"prefix":"10.1093","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-3061","authenticated-orcid":false,"given":"Anand","family":"Odedra","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Woodford","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Chalon","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget E","family":"Barber","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"2022030208294141800_CIT0001","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiab332","article-title":"Safety and tolerability of mosquito-bite induced controlled human infection with","volume":"225","author":"Kamau","year":"2022","journal-title":"J Infect Dis"},{"key":"2022030208294141800_CIT0002","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.4269\/ajtmh.20-0491","article-title":"Liver function test abnormalities in experimental and clinical Plasmodium vivax infection.","volume":"103","author":"Odedra","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2022030208294141800_CIT0003","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.19-0846","article-title":"Liver enzyme elevations in Plasmodium falciparum volunteer infection studies: findings and recommendations.","volume":"103","author":"Chughlay","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2022030208294141800_CIT0004","doi-asserted-by":"crossref","first-page":"e0005139","DOI":"10.1371\/journal.pntd.0005139","article-title":"Safety and reproducibility of a clinical trial system using induced blood stage Plasmodium vivax infection and its potential as a model to evaluate malaria transmission.","volume":"10","author":"Griffin","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2022030208294141800_CIT0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ebiom.2018.09.018","article-title":"Liver injury in uncomplicated malaria is an overlooked phenomenon: an observational study.","volume":"36","author":"Reuling","year":"2018","journal-title":"EBioMedicine"},{"key":"2022030208294141800_CIT0006","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial.","volume":"391","author":"West African Network for Clinical Trials of Antimalarial Drugs (WANECAM).","year":"2018","journal-title":"Lancet"},{"key":"2022030208294141800_CIT0007","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4269\/ajtmh.17-0754","article-title":"The dynamics of liver function test abnormalities after malaria infection: a retrospective observational study.","volume":"98","author":"Woodford","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2022030208294141800_CIT0008","doi-asserted-by":"crossref","first-page":"e0005070","DOI":"10.1371\/journal.pntd.0005070","article-title":"Protective efficacy of Plasmodium vivax radiation-attenuated sporozoites in Colombian volunteers: a randomized controlled trial.","volume":"10","author":"Ar\u00e9valo-Herrera","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2022030208294141800_CIT0009","doi-asserted-by":"crossref","first-page":"e99754","DOI":"10.1371\/journal.pone.0099754","article-title":"Plasmodium vivax sporozoite challenge in malaria-na\u00efve and semi-immune Colombian volunteers.","volume":"9","author":"Ar\u00e9valo-Herrera","year":"2014","journal-title":"PLoS One"},{"key":"2022030208294141800_CIT0010","volume-title":"Guidance for industry drug-induced liver injury: premarketing clinical evaluation","author":"Food and Drug Administration (FDA).","year":"2009"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab502\/41716451\/jiab502.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/5\/926\/42662229\/jiab502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/5\/926\/42662229\/jiab502.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T08:30:29Z","timestamp":1646209829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/5\/926\/6381633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,10,5]]},"published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab502","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,10,5]]}}}